Key result
In 1,303 cryoablation procedures for tachycardias near the AV node, transient AV block occurred in 12.1% of cases but resolved quickly, with no late AV block observed.
Why the study?
Is focal cryoablation adjacent to the AV node safe with respect to the risk of permanent AV block in patients with supraventricular tachycardias?
Is focal cryoablation adjacent to the AV node safe with respect to the risk of permanent AV block in patients with supraventricular tachycardias?
Answers are grounded in this paper and cite their sources.
This editorial highlights that focal cryoablation adjacent to the AV node is highly safe, with transient AV block being a benign finding and no permanent AV block observed.
This editorial refers to ‘Cryoablation of substrates adjacent to the atrioventricular node: acute and long-term safety of 1303 ablation procedures’ by P. Insulander et al., on page 271. In this issue of the Journal, Insulander et al.1 report on the safety of cryoablation for tachycardias mediated by therapeutic targets located near the atrioventricular (AV) node, including accessory pathways, AV nodal reentrant tachycardia (AVNRT), and atrial tachycardias.1 The focus of their study was the short- and long-term risk of AV block due to injury to the normal conduction system in 1303 cryoablation procedures. The median age of the study population was 51 years. The primary diagnosis was AVNRT in 1116 (86%) patients, septal or para-hisian accessory pathways in 100 (7.5%), and focal atrial tachycradia in 87 (6.5%). Transient AV block was observed during 158 procedures, including first-, second-, and third-degree block in 74, 67, and 17 cases, respectively. In 38 patients, AV block developed during cryomapping and in 120 during cryoablation. Except for two cases of recovery after 21 and 45 min, respectively, all episodes of the AV block resolved within seconds. No late AV block was observed. This large safety study of focal cryoablation adjacent to the AV node suggests that transient AV block occurring during the procedure is a benign finding. Cryotherapy, or the use of freezing temperatures to elicit a specific tissue response, has a long history of safety and effectiveness in the treatment of arrhythmias. Radiofrequency (RF) energy is highly effective in the treatment of supraventricular tachyarrhythmias; however, it may create immediate irreversible lesions which may cause permanent AV nodal injury. When RF ablation only is available, the procedure may be interrupted and left unfinished because of the proximity of the therapeutic target to the normal conduction system. One of the major advantages of cryotherapy is cryomapping, originally described by Dubuc and coworkers.2,3 It consists of cryoablation for 20–30 s, a limited period during which the lesion creation is slow and is preceded by a zone of low temperature with reversible effects on the tissue conductive properties. Most investigators recommend a −30°C inferior temperature limit when cryomapping, while others fast freeze the target site down to −70°C, a technique found more effective when searching for the optimal site and uncomplicated by permanent block. Whether cryomapping should be systematically applied as recommended is not clear. In the study by Insulander et al.,1 the majority of transient episodes of AV block developed during the cryoablation phase without being complicated by abnormal conduction in the long term. Cryoablation is often a longer procedure than RF ablation, and cryomapping to −30°C may be ineffective, because of the depth of the slow pathway. Several centres have adopted the outright delivery of cryomapping down to −70°C, which, in the absence of efficacy, is ended after 20 or 30 s. An advantage of cryoablation with respect to the risk of AV node injury is the bond of the catheter to the tissue. In contrast to RF ablation, where the catheter remains free-floating during energy delivery, cryothermy is associated with a freeze-mediated bond of the catheter to the target tissue. This stability of the catheter facilitates the ablation of regions where maintaining contact is challenging and, in contrast to RF ablation, prevents the delivery of energy to both the target and non-target tissues because of the ‘brushing effect’ due to cardiac and respiratory motions.4 One might expect, therefore, that a greater catheter stability would result in less collateral damage to nearby critical structures, such as the AV node. Specifically, ablation can be safely performed while an arrhythmia or programmed electrical stimulation are on-going as there is no risk of catheter dislodgement upon termination of the arrhythmia. The reported series is remarkable by the absence of AV nodal complications.1 Except for some antidromic tachycardias or malignant cases of Wolf–Parkinson–White syndrome, most reentrant and non-reentrant supraventricular tachycardias are not life-threatening. Therefore, major complications such as complete AV block and pacemaker implantation, which occur in 0.2–3.3% of RF ablations, are unacceptable.5 These complications have never been reported with cryoablation, and this study amply confirms the safety of the procedure. The 24-month results, previously published by the same team, seem equally excellent and similar to the results achieved with RF ablation.6 There was no relationship between the occurrence of AV block during the ablation procedure and the risk of long-term AV block. The main indication for cryoablation is AVNRT. While the absence of long-term complications fully justifies the choice of this energy, several comments are in order. The mode of onset of AVNRT cannot always be ascertained. The ‘jump’ might be missing, the tachycardia might not be triggered, the trigger and the jump might be unpredictable, etc. In such cases, success of cryoablation might be hard to verify, in the absence of a marker of the slow pathway represented by junctional rhythm observed during RF ablation. In order to reach the same success rate with cryoablation as with RF, where modulation of the slow pathway suffices, all signs of the slow pathway must be eliminated, which might be very difficult to achieve. Moreover, while persistent dual-AV nodal conduction with a single echo beat during isoproterenol infusion is an acceptable therapeutic target of RF ablation, it is unclear whether this would be an acceptable endpoint for cryoablation. When the tachycardia cannot be induced, or in the absence of a reproducible marker of the slow pathway, cryoablation is a highly empirical procedure, where success is even more elusive. On the other hand, cryomapping may be a valuable technique to localize safely and precisely the higher-risk mid-septal or para-hisian accessory pathways. While the cryoablation procedure can be as short as RF-based, it can also be protracted and less tolerable for the patient, probably when the slow pathway is deep or the shape of the catheter is poorly adapted. The absence of discomfort is a more debatable argument, as focal ablation is nearly painless, particularly on the septum or in the para-hisian region. Pain caused by the RF is mostly a concern with ablation procedures performed from inside the coronary sinus, or near the inferior vena cava. Another point of discussion pertains to the 4, 6, or 8 mm catheter tips. The size of the catheter can be a major determinant of procedural success. Currently, 6 mm catheters are preferred for the treatment of AVNRT, while 4 mm catheters are relatively ineffective,3 and 8 mm are reserved for the treatment of challenging anteroseptal accessory pathways. The downside of the 6 or 8 mm compared with the 4 mm tip is the undesirable recording of far- and near-field potentials, which lower the accuracy of mapping and, consequently, of the ablation procedure. In addition, the 8 mm tipped cryocatheter is stiffer than other catheters and difficult to manipulate, especially in small, paediatric cardiac chambers. A single manufacturer holds a monopole of all the products of cryoablation. As opposed to the RF, this absence of competition has slowed the development of catheters, which remain too stiff for some anatomical presentations. Consequently, these rigid and non-compliant catheters play a role in some procedural failures, when the tip needs to be in close contact with the slow pathway. A consensus is developing in support of the delivery of two, 4 min cryoapplications, as it appears that a double (freeze–thaw–freeze) cycle enhances the lesion formation. The rate and extent of cold front propagation increase with repetitive exposures, suggesting a progressive increase in thermal tissue conductivity.3 In a recent, single-centre study of 53 patients, a low recurrence rate was observed after treatment of AVNRT using triple freeze–thaw cycles.7 The authors found this procedural modification safe and capable of achieving outcomes similar to RF, with a recurrence of tachycardia observed in a single patient (2%) over a mean follow-up of 31 months. Another advantage is the low stress experienced by the operator as well as the patient, attributable to the less compelling need to maintain pressure on the catheter during the procedure, due to its bond with the therapeutic target.8 While cryoablation is quite attractive for the treatment of AVNRT, expert tertiary centres should probably be able to offer both RF and cryoablation, and choose the technique best suitable for specific patients, i.e. cryoablation for paediatric cases and for patients in whom the angle between the AV node and the coronary sinus ostium is narrow. In a young patient, the consequences of developing AV block outweigh the advantages of eliminating what is most often a problematic although not life-threatening disorder. A lifetime of pacing for a young patient is more serious than for an adult, who develops AV block as a complication of ablation. The preference to avoid the risk of AV block leaves a sizable proportion of young patients with no other option than medical therapy. When the substrate is near the AV conduction system, an RF ablation procedure might be deferred. The study by Insulander et al.1 confirms the long-term safety of cryoablating near the sensitive structures such as the AV node. However, studies comparing RF with cryoablation have not convincingly shown the superiority of the latter, because cryoablation seems to be associated with a higher rate of long-term recurrences of tachycardia, and because, in the hands of a well-trained team, risk of AV block associated with RF is low. In the CYRANO study, which compared outcome of 251 cryoablations and 258 RF ablations of slow pathways, the rate of post-procedural complete AV block was similar (0 vs. 0.4%).5 However, the rate of AVNRT recurrences was significantly higher after cryoablation than after RF (9.4 vs. 4.4%; P= 0.029). The potential benefits conferred by cryoenergy from the standpoint of ablation safety and pain perception are counterbalanced by longer procedure times, higher device-related complications, and higher recurrence rates. Cryoablation is here to stay, particularly in the younger population,9,10 for the treatment of arrhythmic substrates that are near the AV node and His bundle, areas where the risk of complications of RF energy delivery is increased.11 The balance between the recurrence rate and safety is likely to be acceptable in most cases. Paediatric programmes, where electrophysiology laboratories cannot afford cryoablation equipment, must recognize the published evidence of its efficacy and safety and refer appropriate cases to centres where this technology is available. In order to provide quality care, tertiary centres not limited to paediatric electrophysiology must have this system at their disposal. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Pascal Defaye (2013) conducted an editorial in Tachycardias near the atrioventricular node (AVNRT, accessory pathways, atrial tachycardias) (n=1,303). Cryoablation was evaluated on Transient AV block. In 1,303 cryoablation procedures for tachycardias near the AV node, transient AV block occurred in 12.1% of cases but resolved quickly, with no late AV block observed.
Synapse has enriched 10 related papers. Consider them for comparative context: